| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2013PLoSO...870198L |
| P356 | DOI | 10.1371/JOURNAL.PONE.0070198 |
| P932 | PMC publication ID | 3742732 |
| P698 | PubMed publication ID | 23967071 |
| P5875 | ResearchGate publication ID | 256073025 |
| P2093 | author name string | Wan-Yu Lo | |
| Nai-Wen Chang | |||
| P2860 | cites work | Control of apoptosis and mitotic spindle checkpoint by survivin | Q22008570 |
| Global cancer statistics | Q22241238 | ||
| HBXIP functions as a cofactor of survivin in apoptosis suppression | Q24303423 | ||
| Human inhibitor of apoptosis proteins: why XIAP is the black sheep of the family | Q24670396 | ||
| Inhibition of cyclin-dependent kinase 1 (CDK1) by indirubin derivatives in human tumour cells | Q28346772 | ||
| IAP proteins: blocking the road to death's door | Q29619844 | ||
| The specificities of protein kinase inhibitors: an update | Q30014834 | ||
| IAP regulation of metastasis | Q33638504 | ||
| Indirubin derivatives inhibit Stat3 signaling and induce apoptosis in human cancer cells | Q33770989 | ||
| The plasminogen activation system in tumor growth, invasion, and metastasis | Q34008816 | ||
| Indirubin inhibits tumor growth by antitumor angiogenesis via blocking VEGFR2-mediated JAK/STAT3 signaling in endothelial cell. | Q34157601 | ||
| Indirubin and meisoindigo in the treatment of chronic myelogenous leukemia in China | Q35103342 | ||
| Signaling pathways responsible for cancer cell invasion as targets for cancer therapy | Q35793957 | ||
| Molecular mechanisms of indirubin and its derivatives: novel anticancer molecules with their origin in traditional Chinese phytomedicine | Q35876121 | ||
| State-of-the-art management of locally advanced head and neck cancer | Q36104471 | ||
| 4-nitroquinoline-1-oxide induced experimental oral carcinogenesis. | Q36382888 | ||
| Terameprocol, a novel site-specific transcription inhibitor with anticancer activity. | Q37098746 | ||
| The importance of determining the aggressiveness of prostate cancer using serum and tissue molecular markers | Q37135804 | ||
| Cancer cells survive with survivin | Q37185505 | ||
| Head and neck cancer in the betel quid chewing area: recent advances in molecular carcinogenesis | Q37255286 | ||
| Survivin multifaceted activity in head and neck carcinoma: current evidence and future therapeutic challenges | Q37424024 | ||
| Biomarkers in dysplasia of the oral cavity: a systematic review. | Q37482415 | ||
| The role of focal adhesion kinase in tumor initiation and progression. | Q37582150 | ||
| Crude extracts of Agaricus brasiliensis induce apoptosis in human oral cancer CAL 27 cells through a mitochondria-dependent pathway | Q39541448 | ||
| Safrole induces apoptosis in human oral cancer HSC-3 cells. | Q39617685 | ||
| Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance | Q39651833 | ||
| Evaluation of survivin as a prognostic marker in oral squamous cell carcinoma | Q39755799 | ||
| Berberine suppresses in vitro migration and invasion of human SCC-4 tongue squamous cancer cells through the inhibitions of FAK, IKK, NF-kappaB, u-PA and MMP-2 and -9. | Q39878536 | ||
| Critical role of Bid and Bax in indirubin-3'-monoxime-induced apoptosis in human cancer cells | Q39996865 | ||
| Indirubin-3'-monoxime inhibits autophosphorylation of FGFR1 and stimulates ERK1/2 activity via p38 MAPK. | Q40126914 | ||
| An IAP-IAP complex inhibits apoptosis | Q40541576 | ||
| Urokinase plasminogen activator/urokinase-specific surface receptor expression and matrix invasion by breast cancer cells requires constitutive p38alpha mitogen-activated protein kinase activity | Q40886640 | ||
| Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases | Q40918567 | ||
| Indirubin-3'-monoxime blocks vascular smooth muscle cell proliferation by inhibition of signal transducer and activator of transcription 3 signaling and reduces neointima formation in vivo | Q42905361 | ||
| (-)-Epigallocatechin-3-gallate decreases thrombin/paclitaxel-induced endothelial tissue factor expression via the inhibition of c-Jun terminal NH2 kinase phosphorylation | Q43234514 | ||
| Co-treating with arecoline and 4-nitroquinoline 1-oxide to establish a mouse model mimicking oral tumorigenesis | Q43258735 | ||
| Indirubins inhibit glycogen synthase kinase-3 beta and CDK5/p25, two protein kinases involved in abnormal tau phosphorylation in Alzheimer's disease. A property common to most cyclin-dependent kinase inhibitors? | Q43507724 | ||
| Quantitative detection of serum survivin and its relationship with prognostic factors in ovarian cancer. | Q44157108 | ||
| Inhibition of cyclooxygenase-2 suppresses invasiveness of oral squamous cell carcinoma cell lines via down-regulation of matrix metalloproteinase-2 and CD44. | Q46611975 | ||
| Phase I clinical trial of survivin-derived peptide vaccine therapy for patients with advanced or recurrent oral cancer. | Q51739914 | ||
| Indirubin-3'-oxime induces mitochondrial dysfunction and triggers growth inhibition and cell cycle arrest in human neuroblastoma cells. | Q53136248 | ||
| Survivin expression predicts poorer prognosis in patients with areca quid chewing-related oral squamous cell carcinoma in Taiwan. | Q53357514 | ||
| 5'-Nitro-indirubinoxime, an indirubin derivative, suppresses metastatic ability of human head and neck cancer cells through the inhibition of Integrin β1/FAK/Akt signaling. | Q54598990 | ||
| Overexpression of cyclooxygenase-2 is sufficient to induce tumorigenesis in transgenic mice | Q73693790 | ||
| Urokinase regulates vitronectin binding by controlling urokinase receptor oligomerization | Q74190401 | ||
| Serum and urine survivin levels in breast cancer | Q79182821 | ||
| Survivin and inducible nitric oxide synthase production during 4NQO-induced rat tongue carcinogenesis: a possible relationship | Q80146078 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | lip and oral cavity carcinoma | Q55790434 |
| P304 | page(s) | e70198 | |
| P577 | publication date | 2013-01-01 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | An indirubin derivative, indirubin-3'-monoxime suppresses oral cancer tumorigenesis through the downregulation of survivin | |
| P478 | volume | 8 |
| Q50163458 | Effects of indirubin and isatin on cell viability, mutagenicity, genotoxicity and BAX/ERCC1 gene expression |
| Q26784341 | Indirubin and Indirubin Derivatives for Counteracting Proliferative Diseases |
| Q47831357 | Proteomic analysis of oral cancer reveals new potential therapeutic targets involved in the Warburg effect. |
| Q33627725 | Stable Internal Reference Genes for Normalizing Real-Time Quantitative PCR in Baphicacanthus cusia under Hormonal Stimuli and UV Irradiation, and in Different Plant Organs. |
| Q38988591 | The Role of Indirubins in Inflammation and Associated Tumorigenesis. |
Search more.